Consistent with its strategy of expanding in the international arena, Qiagen (NASDAQ:QGEN) recently entered into a co-marketing agreement with China’s largest independent laboratory network KingMed Diagnostics. This deal will make Qiagen’s digene HPV Test broadly available in the Chinese market, which has emerged as one of the leading companion diagnostics markets in the world. However, the financial terms of the agreement were not disclosed.
Qiagen’s digene HPV Test has been widely accepted as … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards